Grant received in 2021

DCCC has funded 200,000 DKKK to the project.

Venous thromboembolism in patients with cancer is common and has a significant impact on the prognosis. Based on this, a multidisciplinary network was established in Denmark in 2018 with the aim to ensure the implementation of the clinical guidelines for the prevention and treatment of venous thromboembolism in patients with cancer. The establishment of the network was supported by the DCCC.

We now want to continue this important work within this important area and focus on patients with lung cancer. The purpose of this initiative is to meet in a multidisciplinary working group in order to plan and organize national multidisciplinary investigatorinitiated studies and attract external research grants, improve the prevention and treatment of these patients, and involve patients as an active partner and identify initiatives that can form the basis for increased patient involvement as well as strengthen international research collaboration within this field.

Multidisciplinary organisation
Aarhus University Hospital

Project stakeholders

  • Thomas Decker Christensen, Consultant, Associate professor, DMSc, PhD, Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Department of Clinical Medicine, Aarhus University. Primary contact, Mail: tdc@clin.au.dk
  • Frank V. de Paoli, Afdelingslæge, Associate professor, PhD, Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Department of Biomedicine, Aarhus University
  • Amalie Lambert Kristensen, Registrar, Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital
  • Torben Bjerregaard Larsen, Professor, Specialist Consultant, PhD, Fellowship - European Society of Cardiology, Enhed for trombose og lægemiddelforskning, Aalborg University, Kardiologisk Afdeling, Aalborg University Hospital
  • Mette Søgaard, Senior epidemiolog, Associate professor, PhD, Enhed for trombose og lægemiddelforskning, Aalborg University, Department of cardiology, Aalborg University Hospital
  • Flemming Skjøth, Biostatician, Associate professor, PhD, Enhed for trombose og lægemiddelforskning, Aalborg University, Unit of Clinical Biostatistics, Aalborg Universitetshospital
  • Anne Gulbech Ording, Senior epidemiologist, PhD, Enhed for trombose og lægemiddelforskning, Aalborg University, Department of cardiology, Aalborg University Hospital
  • Anette Arbjerg Højen, nurse, cand.cur., post doc., PhD, Trombosis Centre Aalborg, Aalborg University Hospital
  • Erik Jakobsen, Consultant, Clinical Associate Professor, Cardiac, Thoracic and vascular surgery, Odense University Hospital, Danish Lung Cancer Register
  • Rene H. Petersen, Professor, Consultant, PhD, ​The Department of Cardiothoracic Surgery, Rigshospitalet
  • Peter Meldgaard, Consultant, Associate professor, PhD, Department of Oncology, Aarhus Universitetshospital